Skip to main content
Top
Published in: Journal of Neurology 2/2014

Open Access 01-09-2014 | Review

Central ocular motor disorders, including gaze palsy and nystagmus

Authors: M. Strupp, O. Kremmyda, C. Adamczyk, N. Böttcher, C. Muth, C. W. Yip, T. Bremova

Published in: Journal of Neurology | Special Issue 2/2014

Login to get access

Abstract

An impairment of eye movements, or nystagmus, is seen in many diseases of the central nervous system, in particular those affecting the brainstem and cerebellum, as well as in those of the vestibular system. The key to diagnosis is a systematic clinical examination of the different types of eye movements, including: eye position, range of eye movements, smooth pursuit, saccades, gaze-holding function and optokinetic nystagmus, as well as testing for the different types of nystagmus (e.g., central fixation nystagmus or peripheral vestibular nystagmus). Depending on the time course of the signs and symptoms, eye movements often indicate a specific underlying cause (e.g., stroke or neurodegenerative or metabolic disorders). A detailed knowledge of the anatomy and physiology of eye movements enables the physician to localize the disturbance to a specific area in the brainstem (midbrain, pons or medulla) or cerebellum (in particular the flocculus). For example, isolated dysfunction of vertical eye movements is due to a midbrain lesion affecting the rostral interstitial nucleus of the medial longitudinal fascicle, with impaired vertical saccades only, the interstitial nucleus of Cajal or the posterior commissure; common causes with an acute onset are an infarction or bleeding in the upper midbrain or in patients with chronic progressive supranuclear palsy (PSP) and Niemann–Pick type C (NP-C). Isolated dysfunction of horizontal saccades is due to a pontine lesion affecting the paramedian pontine reticular formation due, for instance, to brainstem bleeding, glioma or Gaucher disease type 3; an impairment of horizontal and vertical saccades is found in later stages of PSP, NP-C and Gaucher disease type 3. Gaze-evoked nystagmus (GEN) in all directions indicates a cerebellar dysfunction and can have multiple causes such as drugs, in particular antiepileptics, chronic alcohol abuse, neurodegenerative cerebellar disorders or cerebellar ataxias; purely vertical GEN is due to a midbrain lesion, while purely horizontal GEN is due to a pontomedullary lesion. The pathognomonic clinical sign of internuclear ophthalmoplegia is an impaired adduction while testing horizontal saccades on the side of the lesion in the ipsilateral medial longitudinal fascicule. The most common pathological types of central nystagmus are downbeat nystagmus (DBN) and upbeat nystagmus (UBN). DBN is generally due to cerebellar dysfunction affecting the flocculus bilaterally (e.g., due to a neurodegenerative disease). Treatment options exist for a few disorders: miglustat for NP-C and aminopyridines for DBN and UBN. It is therefore particularly important to identify treatable cases with these conditions.
Literature
1.
go back to reference Leigh RJ, Zee D (2006) The neurology of eye movements. Oxford University Press, Oxford Leigh RJ, Zee D (2006) The neurology of eye movements. Oxford University Press, Oxford
2.
go back to reference Strupp M, Hufner K, Sandmann R, Zwergal A, Dieterich M, Jahn K, Brandt T (2011) Central oculomotor disturbances and nystagmus: a window into the brainstem and cerebellum. Dtsch Arztebl Int 108:197–204PubMedCentralPubMed Strupp M, Hufner K, Sandmann R, Zwergal A, Dieterich M, Jahn K, Brandt T (2011) Central oculomotor disturbances and nystagmus: a window into the brainstem and cerebellum. Dtsch Arztebl Int 108:197–204PubMedCentralPubMed
3.
go back to reference Brandt T, Dieterich M, Strupp M (2013) Vertigo and dizziness—common complaints, 2nd edn. Springer, LondonCrossRef Brandt T, Dieterich M, Strupp M (2013) Vertigo and dizziness—common complaints, 2nd edn. Springer, LondonCrossRef
4.
go back to reference Cnyrim CD, Newman-Toker D, Karch C, Brandt T, Strupp M (2008) Bedside differentiation of vestibular neuritis from central “vestibular pseudoneuritis”. J Neurol Neurosurg Psychiatry 79:458–460CrossRefPubMed Cnyrim CD, Newman-Toker D, Karch C, Brandt T, Strupp M (2008) Bedside differentiation of vestibular neuritis from central “vestibular pseudoneuritis”. J Neurol Neurosurg Psychiatry 79:458–460CrossRefPubMed
5.
go back to reference Kattah JC, Talkad AV, Wang DZ, Hsieh YH, Newman-Toker DE (2009) HINTS to diagnose stroke in the acute vestibular syndrome: three-step bedside oculomotor examination more sensitive than early MRI diffusion-weighted imaging. Stroke 40:3504–3510CrossRefPubMed Kattah JC, Talkad AV, Wang DZ, Hsieh YH, Newman-Toker DE (2009) HINTS to diagnose stroke in the acute vestibular syndrome: three-step bedside oculomotor examination more sensitive than early MRI diffusion-weighted imaging. Stroke 40:3504–3510CrossRefPubMed
7.
go back to reference Brandt T, Dieterich M (1987) Pathological eye-head coordination in roll: tonic ocular tilt reaction in mesencephalic and medullary lesions. Brain 110:649–666CrossRefPubMed Brandt T, Dieterich M (1987) Pathological eye-head coordination in roll: tonic ocular tilt reaction in mesencephalic and medullary lesions. Brain 110:649–666CrossRefPubMed
8.
go back to reference Dieterich M, Brandt T (1993) Ocular torsion and perceived vertical in oculomotor, trochlear and abducens nerve palsies. Brain 116:1095–1104CrossRefPubMed Dieterich M, Brandt T (1993) Ocular torsion and perceived vertical in oculomotor, trochlear and abducens nerve palsies. Brain 116:1095–1104CrossRefPubMed
9.
go back to reference Dieterich M, Brandt T (1992) Wallenberg’s syndrome: lateropulsion, cyclorotation and subjective visual vertical in thirty-six patients. Ann Neurol 31:399–408CrossRefPubMed Dieterich M, Brandt T (1992) Wallenberg’s syndrome: lateropulsion, cyclorotation and subjective visual vertical in thirty-six patients. Ann Neurol 31:399–408CrossRefPubMed
10.
go back to reference Dieterich M, Brandt T (1993) Ocular torsion and tilt of subjective visual vertical are sensitive brainstem signs. Ann Neurol 33:292–299CrossRefPubMed Dieterich M, Brandt T (1993) Ocular torsion and tilt of subjective visual vertical are sensitive brainstem signs. Ann Neurol 33:292–299CrossRefPubMed
11.
go back to reference Halmagyi GM, Brandt T, Dieterich M, Curthoys IS, Stark RJ, Hoyt WF (1990) Tonic contraversive ocular tilt reaction due to unilateral meso-diencephalic lesion. Neurology 40:1503–1509CrossRefPubMed Halmagyi GM, Brandt T, Dieterich M, Curthoys IS, Stark RJ, Hoyt WF (1990) Tonic contraversive ocular tilt reaction due to unilateral meso-diencephalic lesion. Neurology 40:1503–1509CrossRefPubMed
13.
go back to reference Ko MW, Dalmau J, Galetta SL (2008) Neuro-ophthalmologic manifestations of paraneoplastic syndromes. J Neuroophthalmol 28:58–68CrossRefPubMed Ko MW, Dalmau J, Galetta SL (2008) Neuro-ophthalmologic manifestations of paraneoplastic syndromes. J Neuroophthalmol 28:58–68CrossRefPubMed
14.
go back to reference Shallo-Hoffmann J, Schwarze H, Simonsz HJ, Muhlendyck H (1990) A reexamination of end-point and rebound nystagmus in normals. Invest Ophthalmol Vis Sci 31:388–392PubMed Shallo-Hoffmann J, Schwarze H, Simonsz HJ, Muhlendyck H (1990) A reexamination of end-point and rebound nystagmus in normals. Invest Ophthalmol Vis Sci 31:388–392PubMed
15.
go back to reference Marti S, Straumann D, Glasauer S (2005) The origin of downbeat nystagmus: an asymmetry in the distribution of on-directions of vertical gaze-velocity purkinje cells. Ann N Y Acad Sci 1039:548–553CrossRefPubMed Marti S, Straumann D, Glasauer S (2005) The origin of downbeat nystagmus: an asymmetry in the distribution of on-directions of vertical gaze-velocity purkinje cells. Ann N Y Acad Sci 1039:548–553CrossRefPubMed
16.
go back to reference Salsano E, Umeh C, Rufa A, Pareyson D, Zee DS (2012) Vertical supranuclear gaze palsy in Niemann–Pick type C disease. Neurol Sci 33:1225–1232CrossRefPubMed Salsano E, Umeh C, Rufa A, Pareyson D, Zee DS (2012) Vertical supranuclear gaze palsy in Niemann–Pick type C disease. Neurol Sci 33:1225–1232CrossRefPubMed
17.
18.
go back to reference Halmagyi GM, Curthoys IS (2000) A clinical sign of canal paresis. Arch Neurol 45:737–739CrossRef Halmagyi GM, Curthoys IS (2000) A clinical sign of canal paresis. Arch Neurol 45:737–739CrossRef
19.
go back to reference Bartl K, Lehnen N, Kohlbecher S, Schneider E (2009) Head impulse testing using video-oculography. Ann N Y Acad Sci 1164:331–333CrossRefPubMed Bartl K, Lehnen N, Kohlbecher S, Schneider E (2009) Head impulse testing using video-oculography. Ann N Y Acad Sci 1164:331–333CrossRefPubMed
20.
go back to reference Gauthier GM, Vercher JL (1990) Visual vestibular interaction: vestibulo-ocular reflex suppression with head-fixed target fixation. Exp Brain Res 81:150–160CrossRefPubMed Gauthier GM, Vercher JL (1990) Visual vestibular interaction: vestibulo-ocular reflex suppression with head-fixed target fixation. Exp Brain Res 81:150–160CrossRefPubMed
21.
go back to reference Chen AL, Riley DE, King SA, Joshi AC, Serra A, Liao K, Cohen ML, Otero-Millan J, Martinez-Conde S, Strupp M, Leigh RJ (2010) The disturbance of gaze in progressive supranuclear palsy: implications for pathogenesis. Front Neurol 1:147PubMedCentralPubMed Chen AL, Riley DE, King SA, Joshi AC, Serra A, Liao K, Cohen ML, Otero-Millan J, Martinez-Conde S, Strupp M, Leigh RJ (2010) The disturbance of gaze in progressive supranuclear palsy: implications for pathogenesis. Front Neurol 1:147PubMedCentralPubMed
23.
go back to reference Garver WS, Francis GA, Jelinek D, Shepherd G, Flynn J, Castro G, Walsh VC, Coppock DL, Pettit KM, Heidenreich RA, Meaney FJ (2007) The National Niemann–Pick C1 disease database: report of clinical features and health problems. Am J Med Genet A 143A:1204–1211CrossRefPubMed Garver WS, Francis GA, Jelinek D, Shepherd G, Flynn J, Castro G, Walsh VC, Coppock DL, Pettit KM, Heidenreich RA, Meaney FJ (2007) The National Niemann–Pick C1 disease database: report of clinical features and health problems. Am J Med Genet A 143A:1204–1211CrossRefPubMed
24.
go back to reference King G, Sharom FJ (2012) Proteins that bind and move lipids: MsbA and NPC1. Crit Rev Biochem Mol Biol 47:75–95CrossRefPubMed King G, Sharom FJ (2012) Proteins that bind and move lipids: MsbA and NPC1. Crit Rev Biochem Mol Biol 47:75–95CrossRefPubMed
25.
go back to reference Poirier S, Mayer G, Murphy SR, Garver WS, Chang TY, Schu P, Seidah NG (2013) The cytosolic adaptor AP-1A is essential for the trafficking and function of Niemann–Pick type C proteins. Traffic 14:458–469PubMedCentralCrossRefPubMed Poirier S, Mayer G, Murphy SR, Garver WS, Chang TY, Schu P, Seidah NG (2013) The cytosolic adaptor AP-1A is essential for the trafficking and function of Niemann–Pick type C proteins. Traffic 14:458–469PubMedCentralCrossRefPubMed
26.
go back to reference Sevin M, Lesca G, Baumann N, Millat G, Lyon-Caen O, Vanier MT, Sedel F (2007) The adult form of Niemann–Pick disease type C. Brain 130:120–133CrossRefPubMed Sevin M, Lesca G, Baumann N, Millat G, Lyon-Caen O, Vanier MT, Sedel F (2007) The adult form of Niemann–Pick disease type C. Brain 130:120–133CrossRefPubMed
27.
go back to reference Abel LA, Walterfang M, Fietz M, Bowman EA, Velakoulis D (2009) Saccades in adult Niemann–Pick disease type C reflect frontal, brainstem, and biochemical deficits. Neurology 72:1083–1086CrossRefPubMed Abel LA, Walterfang M, Fietz M, Bowman EA, Velakoulis D (2009) Saccades in adult Niemann–Pick disease type C reflect frontal, brainstem, and biochemical deficits. Neurology 72:1083–1086CrossRefPubMed
28.
go back to reference Solomon D, Winkelman AC, Zee DS, Gray L, Buttner-Ennever J (2005) Niemann–Pick type C disease in two affected sisters: ocular motor recordings and brain-stem neuropathology. Ann N Y Acad Sci 1039:436–445CrossRefPubMed Solomon D, Winkelman AC, Zee DS, Gray L, Buttner-Ennever J (2005) Niemann–Pick type C disease in two affected sisters: ocular motor recordings and brain-stem neuropathology. Ann N Y Acad Sci 1039:436–445CrossRefPubMed
29.
go back to reference Walterfang M, Macfarlane MD, Looi JC, Abel L, Bowman E, Fahey MC, Desmond P, Velakoulis D (2012) Pontine-to-midbrain ratio indexes ocular-motor function and illness stage in adult Niemann–Pick disease type C. Eur J Neurol 19:462–467CrossRefPubMed Walterfang M, Macfarlane MD, Looi JC, Abel L, Bowman E, Fahey MC, Desmond P, Velakoulis D (2012) Pontine-to-midbrain ratio indexes ocular-motor function and illness stage in adult Niemann–Pick disease type C. Eur J Neurol 19:462–467CrossRefPubMed
30.
go back to reference Patterson MC, Mengel E, Wijburg FA, Muller A, Schwierin B, Drevon H, Vanier MT, Pineda M (2013) Disease and patient characteristics in NP-C patients: findings from an international disease registry. Orphanet J Rare Dis 8:12PubMedCentralCrossRefPubMed Patterson MC, Mengel E, Wijburg FA, Muller A, Schwierin B, Drevon H, Vanier MT, Pineda M (2013) Disease and patient characteristics in NP-C patients: findings from an international disease registry. Orphanet J Rare Dis 8:12PubMedCentralCrossRefPubMed
31.
go back to reference Klunemann HH, Santosh PJ, Sedel F (2012) Treatable metabolic psychoses that go undetected: what Niemann–Pick type C can teach us. Int J Psychiatry Clin Pract 16:162–169CrossRefPubMed Klunemann HH, Santosh PJ, Sedel F (2012) Treatable metabolic psychoses that go undetected: what Niemann–Pick type C can teach us. Int J Psychiatry Clin Pract 16:162–169CrossRefPubMed
32.
go back to reference Patterson MC, Hendriksz CJ, Walterfang M, Sedel F, Vanier MT, Wijburg F (2012) Recommendations for the diagnosis and management of Niemann–Pick disease type C: an update. Mol Genet Metab 106:330–344CrossRefPubMed Patterson MC, Hendriksz CJ, Walterfang M, Sedel F, Vanier MT, Wijburg F (2012) Recommendations for the diagnosis and management of Niemann–Pick disease type C: an update. Mol Genet Metab 106:330–344CrossRefPubMed
33.
go back to reference Patterson MC, Vecchio D, Prady H, Abel L, Wraith JE (2007) Miglustat for treatment of Niemann–Pick C disease: a randomised controlled study. Lancet Neurol 6:765–772CrossRefPubMed Patterson MC, Vecchio D, Prady H, Abel L, Wraith JE (2007) Miglustat for treatment of Niemann–Pick C disease: a randomised controlled study. Lancet Neurol 6:765–772CrossRefPubMed
34.
go back to reference Pineda M, Wraith JE, Mengel E, Sedel F, Hwu WL, Rohrbach M, Bembi B, Walterfang M, Korenke GC, Marquardt T, Luzy C, Giorgino R, Patterson MC (2009) Miglustat in patients with Niemann–Pick disease Type C (NP-C): a multicenter observational retrospective cohort study. Mol Genet Metab 98:243–249CrossRefPubMed Pineda M, Wraith JE, Mengel E, Sedel F, Hwu WL, Rohrbach M, Bembi B, Walterfang M, Korenke GC, Marquardt T, Luzy C, Giorgino R, Patterson MC (2009) Miglustat in patients with Niemann–Pick disease Type C (NP-C): a multicenter observational retrospective cohort study. Mol Genet Metab 98:243–249CrossRefPubMed
35.
go back to reference Wraith JE, Baumgartner MR, Bembi B, Covanis A, Levade T, Mengel E, Pineda M, Sedel F, Topcu M, Vanier MT, Widner H, Wijburg FA, Patterson MC (2009) Recommendations on the diagnosis and management of Niemann–Pick disease type C. Mol Genet Metab 98:152–165CrossRefPubMed Wraith JE, Baumgartner MR, Bembi B, Covanis A, Levade T, Mengel E, Pineda M, Sedel F, Topcu M, Vanier MT, Widner H, Wijburg FA, Patterson MC (2009) Recommendations on the diagnosis and management of Niemann–Pick disease type C. Mol Genet Metab 98:152–165CrossRefPubMed
36.
go back to reference Hollak CE (2012) An evidence-based review of the potential benefits of taliglucerase alfa in the treatment of patients with Gaucher disease. Core Evid 7:15–20PubMedCentralCrossRefPubMed Hollak CE (2012) An evidence-based review of the potential benefits of taliglucerase alfa in the treatment of patients with Gaucher disease. Core Evid 7:15–20PubMedCentralCrossRefPubMed
37.
go back to reference Benko W, Ries M, Wiggs EA, Brady RO, Schiffmann R, FitzGibbon EJ (2011) The saccadic and neurological deficits in type 3 Gaucher disease. PLoS One 6:e22410PubMedCentralCrossRefPubMed Benko W, Ries M, Wiggs EA, Brady RO, Schiffmann R, FitzGibbon EJ (2011) The saccadic and neurological deficits in type 3 Gaucher disease. PLoS One 6:e22410PubMedCentralCrossRefPubMed
38.
go back to reference Desnick RJ (2004) Enzyme replacement and enhancement therapies for lysosomal diseases. J Inherit Metab Dis 27:385–410CrossRefPubMed Desnick RJ (2004) Enzyme replacement and enhancement therapies for lysosomal diseases. J Inherit Metab Dis 27:385–410CrossRefPubMed
39.
go back to reference Schiffmann R, FitzGibbon EJ, Harris C, DeVile C, Davies EH, Abel L, van Schaik IN, Benko W, Timmons M, Ries M, Vellodi A (2008) Randomized, controlled trial of miglustat in Gaucher’s disease type 3. Ann Neurol 64:514–522PubMedCentralCrossRefPubMed Schiffmann R, FitzGibbon EJ, Harris C, DeVile C, Davies EH, Abel L, van Schaik IN, Benko W, Timmons M, Ries M, Vellodi A (2008) Randomized, controlled trial of miglustat in Gaucher’s disease type 3. Ann Neurol 64:514–522PubMedCentralCrossRefPubMed
40.
go back to reference Cox TM (2010) Eliglustat tartrate, an orally active glucocerebroside synthase inhibitor for the potential treatment of Gaucher disease and other lysosomal storage diseases. Curr Opin Investig Drugs 11:1169–1181PubMed Cox TM (2010) Eliglustat tartrate, an orally active glucocerebroside synthase inhibitor for the potential treatment of Gaucher disease and other lysosomal storage diseases. Curr Opin Investig Drugs 11:1169–1181PubMed
41.
go back to reference Doneda D, Netto CB, Moulin CC, Schwartz IV (2013) Effects of imiglucerase on the growth and metabolism of Gaucher disease type I patients: a systematic review. Nutr Metab (Lond) 10:34CrossRef Doneda D, Netto CB, Moulin CC, Schwartz IV (2013) Effects of imiglucerase on the growth and metabolism of Gaucher disease type I patients: a systematic review. Nutr Metab (Lond) 10:34CrossRef
42.
go back to reference Neudorfer O, Pastores GM, Zeng BJ, Gianutsos J, Zaroff CM, Kolodny EH (2005) Late-onset Tay-Sachs disease: phenotypic characterization and genotypic correlations in 21 affected patients. Genet Med 7:119–123CrossRefPubMed Neudorfer O, Pastores GM, Zeng BJ, Gianutsos J, Zaroff CM, Kolodny EH (2005) Late-onset Tay-Sachs disease: phenotypic characterization and genotypic correlations in 21 affected patients. Genet Med 7:119–123CrossRefPubMed
43.
go back to reference Grosso S, Farnetani MA, Berardi R, Margollicci M, Galluzzi P, Vivarelli R, Morgese G, Ballestri P (2003) GM2 gangliosidosis variant B1 neuroradiological findings. J Neurol 250:17–21CrossRefPubMed Grosso S, Farnetani MA, Berardi R, Margollicci M, Galluzzi P, Vivarelli R, Morgese G, Ballestri P (2003) GM2 gangliosidosis variant B1 neuroradiological findings. J Neurol 250:17–21CrossRefPubMed
44.
go back to reference Walterfang M, Bonnot O, Mocellin R, Velakoulis D (2013) The neuropsychiatry of inborn errors of metabolism. J Inherit Metab Dis 36:687–702CrossRefPubMed Walterfang M, Bonnot O, Mocellin R, Velakoulis D (2013) The neuropsychiatry of inborn errors of metabolism. J Inherit Metab Dis 36:687–702CrossRefPubMed
45.
go back to reference Osher E, Fattal-Valevski A, Sagie L, Urshanski N, Amir-Levi Y, Katzburg S, Peleg L, Lerman-Sagie T, Zimran A, Elstein D, Navon R, Stern N, Valevski A (2011) Pyrimethamine increases beta-hexosaminidase A activity in patients with Late Onset Tay Sachs. Mol Genet Metab 102:356–363CrossRefPubMed Osher E, Fattal-Valevski A, Sagie L, Urshanski N, Amir-Levi Y, Katzburg S, Peleg L, Lerman-Sagie T, Zimran A, Elstein D, Navon R, Stern N, Valevski A (2011) Pyrimethamine increases beta-hexosaminidase A activity in patients with Late Onset Tay Sachs. Mol Genet Metab 102:356–363CrossRefPubMed
46.
go back to reference Salman MS, Ikeda KM (2013) The syndrome of infantile-onset saccade initiation delay. Can J Neurol Sci 40:235–240CrossRefPubMed Salman MS, Ikeda KM (2013) The syndrome of infantile-onset saccade initiation delay. Can J Neurol Sci 40:235–240CrossRefPubMed
47.
go back to reference Harris CM, Shawkat F, Russell-Eggitt I, Wilson J, Taylor D (1996) Intermittent horizontal saccade failure (‘ocular motor apraxia’) in children. Br J Ophthalmol 80:151–158PubMedCentralCrossRefPubMed Harris CM, Shawkat F, Russell-Eggitt I, Wilson J, Taylor D (1996) Intermittent horizontal saccade failure (‘ocular motor apraxia’) in children. Br J Ophthalmol 80:151–158PubMedCentralCrossRefPubMed
48.
go back to reference Le Ber I, Moreira MC, Rivaud-Pechoux S, Chamayou C, Ochsner F, Kuntzer T, Tardieu M, Said G, Habert MO, Demarquay G, Tannier C, Beis JM, Brice A, Koenig M, Durr A (2003) Cerebellar ataxia with oculomotor apraxia type 1: clinical and genetic studies. Brain 126:2761–2772CrossRefPubMed Le Ber I, Moreira MC, Rivaud-Pechoux S, Chamayou C, Ochsner F, Kuntzer T, Tardieu M, Said G, Habert MO, Demarquay G, Tannier C, Beis JM, Brice A, Koenig M, Durr A (2003) Cerebellar ataxia with oculomotor apraxia type 1: clinical and genetic studies. Brain 126:2761–2772CrossRefPubMed
49.
go back to reference Le Ber I, Bouslam N, Rivaud-Pechoux S, Guimaraes J, Benomar A, Chamayou C, Goizet C, Moreira MC, Klur S, Yahyaoui M, Agid Y, Koenig M, Stevanin G, Brice A, Durr A (2004) Frequency and phenotypic spectrum of ataxia with oculomotor apraxia 2: a clinical and genetic study in 18 patients. Brain 127:759–767CrossRefPubMed Le Ber I, Bouslam N, Rivaud-Pechoux S, Guimaraes J, Benomar A, Chamayou C, Goizet C, Moreira MC, Klur S, Yahyaoui M, Agid Y, Koenig M, Stevanin G, Brice A, Durr A (2004) Frequency and phenotypic spectrum of ataxia with oculomotor apraxia 2: a clinical and genetic study in 18 patients. Brain 127:759–767CrossRefPubMed
50.
go back to reference Panouilleres M, Frismand S, Sillan O, Urquizar C, Vighetto A, Pelisson D, Tilikete C (2013) Saccades and eye-head coordination in ataxia with oculomotor apraxia type 2. Cerebellum 12:557–567CrossRefPubMed Panouilleres M, Frismand S, Sillan O, Urquizar C, Vighetto A, Pelisson D, Tilikete C (2013) Saccades and eye-head coordination in ataxia with oculomotor apraxia type 2. Cerebellum 12:557–567CrossRefPubMed
51.
go back to reference Durr A (2010) Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond. Lancet Neurol 9:885–894CrossRefPubMed Durr A (2010) Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond. Lancet Neurol 9:885–894CrossRefPubMed
53.
go back to reference Gispert S, Twells R, Orozco G, Brice A, Weber J, Heredero L, Scheufler K, Riley B, Allotey R, Nothers C (1993) Chromosomal assignment of the second locus for autosomal dominant cerebellar ataxia (SCA2) to chromosome 12q23-24.1. Nat Genet 4:295–299CrossRefPubMed Gispert S, Twells R, Orozco G, Brice A, Weber J, Heredero L, Scheufler K, Riley B, Allotey R, Nothers C (1993) Chromosomal assignment of the second locus for autosomal dominant cerebellar ataxia (SCA2) to chromosome 12q23-24.1. Nat Genet 4:295–299CrossRefPubMed
54.
go back to reference Geiner S, Horn AK, Wadia NH, Sakai H, Buttner-Ennever JA (2008) The neuroanatomical basis of slow saccades in spinocerebellar ataxia type 2 (Wadia-subtype). Prog Brain Res 171:575–581CrossRefPubMed Geiner S, Horn AK, Wadia NH, Sakai H, Buttner-Ennever JA (2008) The neuroanatomical basis of slow saccades in spinocerebellar ataxia type 2 (Wadia-subtype). Prog Brain Res 171:575–581CrossRefPubMed
55.
go back to reference Kim JS, Kim JS, Youn J, Seo DW, Jeong Y, Kang JH, Park JH, Cho JW (2013) Ocular motor characteristics of different subtypes of spinocerebellar ataxia: distinguishing features. Mov Disord 28:1271–1277CrossRefPubMed Kim JS, Kim JS, Youn J, Seo DW, Jeong Y, Kang JH, Park JH, Cho JW (2013) Ocular motor characteristics of different subtypes of spinocerebellar ataxia: distinguishing features. Mov Disord 28:1271–1277CrossRefPubMed
56.
go back to reference Rub U, Brunt ER, Seidel K, Gierga K, Mooy CM, Kettner M, Van Broeckhoven C, Bechmann I, La Spada AR, Schols L, den Dunnen W, de Vos RA, Deller T (2008) Spinocerebellar ataxia type 7 (SCA7): widespread brain damage in an adult-onset patient with progressive visual impairments in comparison with an adult-onset patient without visual impairments. Neuropathol Appl Neurobiol 34:155–168CrossRefPubMed Rub U, Brunt ER, Seidel K, Gierga K, Mooy CM, Kettner M, Van Broeckhoven C, Bechmann I, La Spada AR, Schols L, den Dunnen W, de Vos RA, Deller T (2008) Spinocerebellar ataxia type 7 (SCA7): widespread brain damage in an adult-onset patient with progressive visual impairments in comparison with an adult-onset patient without visual impairments. Neuropathol Appl Neurobiol 34:155–168CrossRefPubMed
57.
go back to reference Strupp M, Teufel J, Habs M, Feuerecker R, Muth C, van de Warrenburg BP, Klopstock T, Feil K (2013) Effects of acetyl-dl-leucine in patients with cerebellar ataxia: a case series. J Neurol 260:2556–2561PubMedCentralCrossRefPubMed Strupp M, Teufel J, Habs M, Feuerecker R, Muth C, van de Warrenburg BP, Klopstock T, Feil K (2013) Effects of acetyl-dl-leucine in patients with cerebellar ataxia: a case series. J Neurol 260:2556–2561PubMedCentralCrossRefPubMed
58.
go back to reference Strupp M, Thurtell MJ, Shaikh AG, Brandt T, Zee DS, Leigh RJ (2011) Pharmacotherapy of vestibular and ocular motor disorders, including nystagmus. J Neurol 258:1207–1222PubMedCentralCrossRefPubMed Strupp M, Thurtell MJ, Shaikh AG, Brandt T, Zee DS, Leigh RJ (2011) Pharmacotherapy of vestibular and ocular motor disorders, including nystagmus. J Neurol 258:1207–1222PubMedCentralCrossRefPubMed
59.
go back to reference Aure K, de Ogier BH, Laforet P, Jardel C, Eymard B, Lombes A (2007) Chronic progressive ophthalmoplegia with large-scale mtDNA rearrangement: can we predict progression? Brain 130:1516–1524CrossRefPubMed Aure K, de Ogier BH, Laforet P, Jardel C, Eymard B, Lombes A (2007) Chronic progressive ophthalmoplegia with large-scale mtDNA rearrangement: can we predict progression? Brain 130:1516–1524CrossRefPubMed
60.
go back to reference DeBrosse S, Ubogu EE, Yaniglos S, Hassan MO, Leigh RJ (2009) Dynamic properties of eye movements in mitochondrial chronic progressive external ophthalmoplegia. Eye (Lond) 23:382–388CrossRef DeBrosse S, Ubogu EE, Yaniglos S, Hassan MO, Leigh RJ (2009) Dynamic properties of eye movements in mitochondrial chronic progressive external ophthalmoplegia. Eye (Lond) 23:382–388CrossRef
61.
go back to reference Ritchie AE, Griffiths PG, Chinnery PF, Davidson AW (2010) Eye movement recordings to investigate a supranuclear component in chronic progressive external ophthalmoplegia: a cross-sectional study. Br J Ophthalmol 94:1165–1168PubMedCentralCrossRefPubMed Ritchie AE, Griffiths PG, Chinnery PF, Davidson AW (2010) Eye movement recordings to investigate a supranuclear component in chronic progressive external ophthalmoplegia: a cross-sectional study. Br J Ophthalmol 94:1165–1168PubMedCentralCrossRefPubMed
62.
go back to reference Moraes CT, DiMauro S, Zeviani M, Lombes A, Shanske S, Miranda AF, Nakase H, Bonilla E, Werneck LC, Servidei S (1989) Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med 320:1293–1299CrossRefPubMed Moraes CT, DiMauro S, Zeviani M, Lombes A, Shanske S, Miranda AF, Nakase H, Bonilla E, Werneck LC, Servidei S (1989) Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med 320:1293–1299CrossRefPubMed
63.
go back to reference Compain C, Sacre K, Puechal X, Klein I, Vital-Durand D, Houeto JL, De BT, Raoult D, Papo T (2013) Central nervous system involvement in Whipple disease: clinical study of 18 patients and long-term follow-up. Medicine (Baltimore) 92:324–330CrossRef Compain C, Sacre K, Puechal X, Klein I, Vital-Durand D, Houeto JL, De BT, Raoult D, Papo T (2013) Central nervous system involvement in Whipple disease: clinical study of 18 patients and long-term follow-up. Medicine (Baltimore) 92:324–330CrossRef
64.
go back to reference Schwartz MA, Selhorst JB, Ochs AL, Beck RW, Campbell WW, Harris JK, Waters B, Velasco ME (1986) Oculomasticatory myorhythmia: a unique movement disorder occurring in Whipple’s disease. Ann Neurol 20:677–683CrossRefPubMed Schwartz MA, Selhorst JB, Ochs AL, Beck RW, Campbell WW, Harris JK, Waters B, Velasco ME (1986) Oculomasticatory myorhythmia: a unique movement disorder occurring in Whipple’s disease. Ann Neurol 20:677–683CrossRefPubMed
66.
go back to reference Wagner JN, Glaser M, Brandt T, Strupp M (2008) Downbeat nystagmus: aetiology and comorbidity in 117 patients. J Neurol Neurosurg Psychiatry 79:672–677CrossRefPubMed Wagner JN, Glaser M, Brandt T, Strupp M (2008) Downbeat nystagmus: aetiology and comorbidity in 117 patients. J Neurol Neurosurg Psychiatry 79:672–677CrossRefPubMed
67.
go back to reference Strupp M, Kremmyda O, Brandt T (2013) Pharmacotherapy of vestibular disorders and nystagmus. Semin Neurol 33:286–296CrossRefPubMed Strupp M, Kremmyda O, Brandt T (2013) Pharmacotherapy of vestibular disorders and nystagmus. Semin Neurol 33:286–296CrossRefPubMed
68.
go back to reference Strupp M, Schuler O, Krafczyk S, Jahn K, Schautzer F, Buttner U, Brandt T (2003) Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study. Neurology 61:165–170CrossRefPubMed Strupp M, Schuler O, Krafczyk S, Jahn K, Schautzer F, Buttner U, Brandt T (2003) Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study. Neurology 61:165–170CrossRefPubMed
69.
go back to reference Kalla R, Deutschlander A, Hufner K, Stephan T, Jahn K, Glasauer S, Brandt T, Strupp M (2006) Detection of floccular hypometabolism in downbeat nystagmus by fMRI. Neurology 66:281–283CrossRefPubMed Kalla R, Deutschlander A, Hufner K, Stephan T, Jahn K, Glasauer S, Brandt T, Strupp M (2006) Detection of floccular hypometabolism in downbeat nystagmus by fMRI. Neurology 66:281–283CrossRefPubMed
70.
go back to reference Claassen J, Spiegel R, Kalla R, Faldon M, Kennard C, Danchaivijitr C, Bardins S, Rettinger N, Schneider E, Brandt T, Jahn K, Teufel J, Strupp M, Bronstein A (2013) A randomised double-blind, cross-over trial of 4-aminopyridine for downbeat nystagmus—effects on slowphase eye velocity, postural stability, locomotion and symptoms. J Neurol Neurosurg Psychiatry 84:1392–1399CrossRefPubMed Claassen J, Spiegel R, Kalla R, Faldon M, Kennard C, Danchaivijitr C, Bardins S, Rettinger N, Schneider E, Brandt T, Jahn K, Teufel J, Strupp M, Bronstein A (2013) A randomised double-blind, cross-over trial of 4-aminopyridine for downbeat nystagmus—effects on slowphase eye velocity, postural stability, locomotion and symptoms. J Neurol Neurosurg Psychiatry 84:1392–1399CrossRefPubMed
71.
go back to reference Kalla R, Glasauer S, Buttner U, Brandt T, Strupp M (2007) 4-aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus. Brain 130:2441–2451CrossRefPubMed Kalla R, Glasauer S, Buttner U, Brandt T, Strupp M (2007) 4-aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus. Brain 130:2441–2451CrossRefPubMed
72.
go back to reference Etzion Y, Grossman Y (2001) Highly 4-aminopyridine sensitive delayed rectifier current modulates the excitability of guinea pig cerebellar Purkinje cells. Exp Brain Res 139:419–425CrossRefPubMed Etzion Y, Grossman Y (2001) Highly 4-aminopyridine sensitive delayed rectifier current modulates the excitability of guinea pig cerebellar Purkinje cells. Exp Brain Res 139:419–425CrossRefPubMed
74.
go back to reference Dieterich M, Straube A, Brandt T, Paulus W, Buttner U (1991) The effects of baclofen and cholinergic drugs on upbeat and downbeat nystagmus. J Neurol Neurosurg Psychiatry 54:627–632PubMedCentralCrossRefPubMed Dieterich M, Straube A, Brandt T, Paulus W, Buttner U (1991) The effects of baclofen and cholinergic drugs on upbeat and downbeat nystagmus. J Neurol Neurosurg Psychiatry 54:627–632PubMedCentralCrossRefPubMed
75.
go back to reference Glasauer S, Kalla R, Buttner U, Strupp M, Brandt T (2005) 4-aminopyridine restores visual ocular motor function in upbeat nystagmus. J Neurol Neurosurg Psychiatry 76:451–453PubMedCentralCrossRefPubMed Glasauer S, Kalla R, Buttner U, Strupp M, Brandt T (2005) 4-aminopyridine restores visual ocular motor function in upbeat nystagmus. J Neurol Neurosurg Psychiatry 76:451–453PubMedCentralCrossRefPubMed
Metadata
Title
Central ocular motor disorders, including gaze palsy and nystagmus
Authors
M. Strupp
O. Kremmyda
C. Adamczyk
N. Böttcher
C. Muth
C. W. Yip
T. Bremova
Publication date
01-09-2014
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue Special Issue 2/2014
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-014-7385-9

Other articles of this Special Issue 2/2014

Journal of Neurology 2/2014 Go to the issue